1. Home
  2. RDY vs RQI Comparison

RDY vs RQI Comparison

Compare RDY & RQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • RQI
  • Stock Information
  • Founded
  • RDY 1984
  • RQI 2002
  • Country
  • RDY India
  • RQI United States
  • Employees
  • RDY N/A
  • RQI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • RQI Trusts Except Educational Religious and Charitable
  • Sector
  • RDY Health Care
  • RQI Finance
  • Exchange
  • RDY Nasdaq
  • RQI Nasdaq
  • Market Cap
  • RDY 2.1B
  • RQI 1.7B
  • IPO Year
  • RDY N/A
  • RQI N/A
  • Fundamental
  • Price
  • RDY $14.60
  • RQI $12.28
  • Analyst Decision
  • RDY Strong Buy
  • RQI
  • Analyst Count
  • RDY 2
  • RQI 0
  • Target Price
  • RDY $16.95
  • RQI N/A
  • AVG Volume (30 Days)
  • RDY 1.4M
  • RQI 432.6K
  • Earning Date
  • RDY 07-28-2025
  • RQI 01-01-0001
  • Dividend Yield
  • RDY 0.56%
  • RQI 8.20%
  • EPS Growth
  • RDY 1.47
  • RQI N/A
  • EPS
  • RDY 0.79
  • RQI N/A
  • Revenue
  • RDY $3,809,801,863.00
  • RQI N/A
  • Revenue This Year
  • RDY $10.24
  • RQI N/A
  • Revenue Next Year
  • RDY N/A
  • RQI N/A
  • P/E Ratio
  • RDY $18.44
  • RQI N/A
  • Revenue Growth
  • RDY 16.61
  • RQI N/A
  • 52 Week Low
  • RDY $12.26
  • RQI $9.17
  • 52 Week High
  • RDY $16.89
  • RQI $12.64
  • Technical
  • Relative Strength Index (RSI)
  • RDY 42.74
  • RQI 44.67
  • Support Level
  • RDY $14.46
  • RQI $12.32
  • Resistance Level
  • RDY $15.25
  • RQI $12.50
  • Average True Range (ATR)
  • RDY 0.18
  • RQI 0.17
  • MACD
  • RDY -0.10
  • RQI -0.01
  • Stochastic Oscillator
  • RDY 16.40
  • RQI 26.60

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About RQI Cohen & Steers Quality Income Realty Fund Inc

COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.

Share on Social Networks: